AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 139 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $5,044,000 | -24.6% | 2,231,966 | -3.9% | 0.07% | -33.9% |
| Q3 2021 | $6,692,000 | +1326.9% | 2,323,517 | +1777.2% | 0.11% | +1111.1% |
| Q2 2021 | $469,000 | -93.0% | 123,774 | -94.8% | 0.01% | -94.9% |
| Q4 2020 | $6,671,000 | -51.3% | 2,382,522 | -56.4% | 0.18% | -60.6% |
| Q3 2020 | $13,702,000 | +56.6% | 5,458,936 | +747.4% | 0.45% | +29.4% |
| Q2 2020 | $8,749,000 | +84.2% | 644,229 | +2.8% | 0.35% | +2.4% |
| Q1 2020 | $4,750,000 | -40.9% | 626,710 | -50.8% | 0.34% | +3.0% |
| Q4 2019 | $8,044,000 | – | 1,272,787 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |